The Impact of Factor VIII/von Willebrand Factor Products in Inhibitor Development and Management of Patients With Hemophilia a With Inhibitors

Oncology & Hematology Review (US)
doi 10.17925/ohr.2007.01.01.14
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Touch Medical Media, Ltd.

Related search

Different Impact of Factor VIII Products on Inhibitor Development?

Thrombosis Journal
Hematology
2016English

Prevalence of Inhibitors to Factor VIII After 25 Exposures to Factor VIII Concentrates and/or Blood Products in Persons With Hemophilia A

Journal of Medical Science And Clinical Research
2017English

Stabilization of Factor VIII in Plasma by the Von Willebrand Factor

Journal of Clinical Investigation
Medicine
1977English

Cerebral Sinus and Venous Thrombosis Associated With Von Willebrand Factor, Independently of Factor VIII

Clinical Medicine: Case Reports
2008English

Improving the Performance of Factor VIII Inhibitor Tests in Hemophilia A

Thrombosis Research
Hematology
2015English

Survival of 125iodine-Labeled Factor VIII in Normals and Patients With Classic Hemophilia. Observations on the Heterogeneity of Human Factor VIII.

Journal of Clinical Investigation
Medicine
1978English

Von Willebrand Factor and Factor VIII Levels After Desmopressin Are Associated With Bleeding Phenotype in Type 1 VWD

Blood advances
Hematology
2019English

Interaction Between the A3 Region of Factor VIII and the TIL’E’ Domains of the Von Willebrand Factor

Biophysical Journal
Biophysics
2019English

Highly Purified Porcine Factor VIII in Haemophilia a With Inhibitors to Factor VIII

BMJ
1981English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy